Addictions Therapeutics Market by Type and Geography - Forecast and Analysis 2019-2023

Addictions Therapeutics Market by Type and Geography - Forecast and Analysis 2019-2023

Global Addictions Therapeutics Market: About this market

Technavio’s addictions therapeutics market analysis considers sales from alcohol addiction therapeutics, tobacco addiction therapeutics, and drug addiction therapeutics type. Our analysis also considers the sales of addictions therapeutics in Asia, Europe, North America, and ROW. In 2018, the alcohol addiction therapeutics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rise in alcohol addiction around the globe will play a significant role in the alcohol addiction therapeutics segment to maintain its market position. Also, our global addictions therapeutics market report looks at factors such as the high consumption of alcohol, tobacco, and opioid products, approval of new drugs and launch of digital therapeutics to treat addiction, and initiatives to increase awareness about and combat addiction. However, minimum insurance coverage for addiction treatment, stringent government policies and regulations, and social stigma among the drug-addicted population may hamper the growth of the addictions therapeutics industry over the forecast period.

Global Addictions Therapeutics Market: Overview

Initiatives to increase awareness about and combat addiction

There is an increase in the awareness about substance abuse and combat drug abuse due to the growing number of initiatives undertaken by federal departments and agencies. For instance, in India, drug abuse among the population is high, particularly in areas of Punjab, Haryana, and Uttar Pradesh. Therefore, the government of these states has undertaken special steps to combat drug abuse. They are providing information and resources to increase the understanding of addiction, drug and alcohol prevention, awareness about heroin/opioid epidemic, and more. Such initiatives will boost the demand for addiction therapeutics and lead to the expansion of the global addictions therapeutics market at a CAGR of over 5% during the forecast period.

Emergence of free state-run addiction treatment programs and facilities

Free treatment facilities and addiction treatment programs are available for those individuals struggling with substance use disorders who cannot otherwise afford the treatment. State-funded drug rehabilitation centers provide services such as free detox, inpatient facility stay, outpatient services, and other drug rehabilitation services. The availability of these treatment facilities is increasing the demand for addiction therapeutics. These free clinics and rehabilitation centers help people who are struggling with the physical, emotional, and financial costs of addiction. This is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global addictions therapeutics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global addictions therapeutics market is moderately fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading addictions therapeutics manufacturers, that include Alkermes Plc, Amneal Pharmaceuticals Inc., Indivior Plc, Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Novo Nordisk AS, Novo Nordisk AS, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

Also, the addictions therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
      • Table Product overview
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • Alcohol addiction therapeutics - Market size and forecast 2018-2023
      • Table Alcohol addiction therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Alcohol addiction therapeutics - Year-over-year growth 2019-2023 (%)
    • Tobacco addiction therapeutics - Market size and forecast 2018-2023
      • Table Tobacco addiction therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Tobacco addiction therapeutics - Year-over-year growth 2019-2023 (%)
    • Drug addiction therapeutics - Market size and forecast 2018- 2023
      • Table Drug addiction therapeutics - Market size and forecast 2018-2023 ($ millions)
      • Table Drug addiction therapeutics - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market Trends
    • Increasing R&D of novel drugs
    • Emergence of free state-run addiction treatment programs and facilities
    • Consolidation of rehabilitation centers
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Alkermes Plc
      • Table Alkermes Plc - Vendor overview
      • Table Alkermes Plc - Business segments
      • Table Alkermes Plc - Organizational developments
      • Table Alkermes Plc - Geographic focus
      • Table Alkermes Plc - Key offerings
      • Table Alkermes Plc - Key customers
    • Amneal Pharmaceuticals Inc.
      • Table Amneal Pharmaceuticals Inc. - Vendor overview
      • Table Amneal Pharmaceuticals Inc. - Business segments
      • Table Amneal Pharmaceuticals Inc. - Organizational developments
      • Table Amneal Pharmaceuticals Inc. - Segment focus
      • Table Amneal Pharmaceuticals Inc. - Key offerings
      • Table Amneal Pharmaceuticals Inc. - Key customers
    • Indivior Plc
      • Table Indivior Plc - Vendor overview
      • Table Indivior Plc - Business segments
      • Table Indivior Plc - Organizational developments
      • Table Indivior Plc - Geographic focus
      • Table Indivior Plc - Key offerings
      • Table Indivior Plc - Key customers
    • Johnson & Johnson Services Inc.
      • Table Johnson & Johnson Services Inc. - Vendor overview
      • Table Johnson & Johnson Services Inc. - Business segments
      • Table Johnson & Johnson Services Inc. - Organizational developments
      • Table Johnson & Johnson Services Inc. - Geographic focus
      • Table Johnson & Johnson Services Inc. - Segment focus
      • Table Johnson & Johnson Services Inc. - Key offerings
      • Table Johnson & Johnson Services Inc. - Key customers
    • Mylan NV
      • Table Mylan NV - Vendor overview
      • Table Mylan NV - Product segments
      • Table Mylan NV - Organizational developments
      • Table Mylan NV - Geographic focus
      • Table Mylan NV - Segment focus
      • Table Mylan NV - Key offerings
      • Table Mylan NV - Key customers
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Key customers
    • Novo Nordisk AS
      • Table Novo Nordisk AS - Vendor overview
      • Table Novo Nordisk AS - Business segments
      • Table Novo Nordisk AS - Organizational developments
      • Table Novo Nordisk AS - Geographic focus
      • Table Novo Nordisk AS - Segment focus
      • Table Novo Nordisk AS - Key offerings
      • Table Novo Nordisk AS - Key customers
    • Opiant Pharmaceuticals Inc.
      • Table Opiant Pharmaceuticals Inc. - Vendor overview
      • Table Opiant Pharmaceuticals Inc. - Business segments
      • Table Opiant Pharmaceuticals Inc. - Organizational developments
      • Table Opiant Pharmaceuticals Inc. - Key offerings
      • Table Opiant Pharmaceuticals Inc. - Key customers
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Key customers
    • Teva Pharmaceutical Industries Ltd.
      • Table Teva Pharmaceutical Industries Ltd. - Vendor overview
      • Table Teva Pharmaceutical Industries Ltd. - Business segments
      • Table Teva Pharmaceutical Industries Ltd. - Organizational developments
      • Table Teva Pharmaceutical Industries Ltd. - Segment focus
      • Table Teva Pharmaceutical Industries Ltd. - Key offerings
      • Table Teva Pharmaceutical Industries Ltd. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook